Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
Legacy MEDSearch
APRIL 6, 2023
The FDA clearance opens the door to the world’s largest medical device market. To this day, CardioSTAT has been prescribed to more than 170,000 patients. With this clearance, Icentia will be able to pursue its mission of becoming a world leader in ambulatory cardiac monitoring by extending its market to the United States.
Let's personalize your content